Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Actins | 5 | 2022 | 164 | 0.590 |
Why?
|
| Endosomes | 2 | 2010 | 33 | 0.560 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2017 | 6 | 0.530 |
Why?
|
| Mutation | 2 | 2024 | 1177 | 0.520 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2022 | 199 | 0.410 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 734 | 0.400 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2010 | 1 | 0.340 |
Why?
|
| Molecular Motor Proteins | 1 | 2010 | 9 | 0.340 |
Why?
|
| Drosophila | 1 | 2010 | 152 | 0.310 |
Why?
|
| Drosophila Proteins | 1 | 2010 | 188 | 0.290 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 2022 | 110 | 0.280 |
Why?
|
| Microtubules | 3 | 2017 | 121 | 0.260 |
Why?
|
| Tropomyosin | 1 | 2006 | 16 | 0.260 |
Why?
|
| Saccharomycetales | 1 | 2006 | 8 | 0.260 |
Why?
|
| Myosin Type II | 1 | 2006 | 17 | 0.260 |
Why?
|
| Diabetic Retinopathy | 2 | 2016 | 78 | 0.230 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2024 | 46 | 0.210 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2006 | 28 | 0.210 |
Why?
|
| Endocytosis | 1 | 2004 | 118 | 0.210 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2024 | 139 | 0.200 |
Why?
|
| Protein Structure, Tertiary | 2 | 2017 | 423 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 159 | 0.200 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2024 | 257 | 0.190 |
Why?
|
| Cell Division | 1 | 2002 | 311 | 0.180 |
Why?
|
| Mitochondria | 2 | 2022 | 523 | 0.180 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 307 | 0.180 |
Why?
|
| Longevity | 1 | 2022 | 173 | 0.160 |
Why?
|
| Ovarian Follicle | 1 | 2020 | 44 | 0.160 |
Why?
|
| Protein Binding | 3 | 2017 | 1082 | 0.160 |
Why?
|
| Fishes | 1 | 2020 | 73 | 0.150 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2016 | 131 | 0.140 |
Why?
|
| Biocatalysis | 1 | 2017 | 30 | 0.130 |
Why?
|
| Binding, Competitive | 1 | 2017 | 109 | 0.130 |
Why?
|
| Hydrolysis | 1 | 2017 | 97 | 0.130 |
Why?
|
| Protein Transport | 2 | 2010 | 296 | 0.130 |
Why?
|
| Magnesium | 1 | 2017 | 94 | 0.130 |
Why?
|
| Exosomes | 1 | 2019 | 126 | 0.130 |
Why?
|
| Animals | 10 | 2024 | 16992 | 0.130 |
Why?
|
| Retinal Neovascularization | 1 | 2016 | 10 | 0.130 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 206 | 0.120 |
Why?
|
| Leucine | 1 | 2016 | 31 | 0.120 |
Why?
|
| Protein Multimerization | 1 | 2017 | 115 | 0.120 |
Why?
|
| Amino Acid Sequence | 2 | 2010 | 1180 | 0.120 |
Why?
|
| Receptors, LDL | 1 | 2016 | 42 | 0.120 |
Why?
|
| Manganese | 1 | 2017 | 92 | 0.120 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2016 | 62 | 0.120 |
Why?
|
| Molecular Sequence Data | 2 | 2010 | 1542 | 0.120 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 518 | 0.120 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2017 | 188 | 0.120 |
Why?
|
| Binding Sites | 1 | 2017 | 671 | 0.120 |
Why?
|
| Apolipoproteins E | 1 | 2016 | 138 | 0.120 |
Why?
|
| Cytoskeleton | 2 | 2006 | 114 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 223 | 0.110 |
Why?
|
| Peptide Fragments | 1 | 2016 | 307 | 0.110 |
Why?
|
| Retina | 1 | 2016 | 289 | 0.100 |
Why?
|
| Mice | 6 | 2024 | 6644 | 0.100 |
Why?
|
| Cell Line, Tumor | 3 | 2024 | 2676 | 0.090 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2010 | 12 | 0.080 |
Why?
|
| Cell Movement | 3 | 2019 | 655 | 0.080 |
Why?
|
| Biophysics | 1 | 2010 | 38 | 0.080 |
Why?
|
| Molecular Weight | 1 | 2010 | 168 | 0.080 |
Why?
|
| Dimerization | 1 | 2010 | 112 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 189 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 2 | 2006 | 209 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 1723 | 0.060 |
Why?
|
| Blotting, Western | 3 | 2016 | 883 | 0.060 |
Why?
|
| Cell Line | 1 | 2010 | 1410 | 0.060 |
Why?
|
| Microtubule-Organizing Center | 1 | 2006 | 3 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2006 | 29 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2006 | 139 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 267 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 296 | 0.060 |
Why?
|
| Protein Kinase C | 1 | 2006 | 124 | 0.060 |
Why?
|
| Actin-Related Protein 2 | 1 | 2004 | 2 | 0.060 |
Why?
|
| Actin-Related Protein 3 | 1 | 2004 | 2 | 0.060 |
Why?
|
| Cell Compartmentation | 1 | 2004 | 12 | 0.060 |
Why?
|
| Lactams | 1 | 2024 | 10 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2006 | 281 | 0.060 |
Why?
|
| Hydroxamic Acids | 1 | 2024 | 33 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 92 | 0.050 |
Why?
|
| Acetylation | 1 | 2024 | 107 | 0.050 |
Why?
|
| Aminopyridines | 1 | 2024 | 26 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2006 | 321 | 0.050 |
Why?
|
| Histone Deacetylases | 1 | 2024 | 61 | 0.050 |
Why?
|
| Lysine | 1 | 2024 | 119 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2024 | 103 | 0.050 |
Why?
|
| Movement | 1 | 2004 | 119 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2024 | 260 | 0.050 |
Why?
|
| Drug Discovery | 1 | 2024 | 108 | 0.050 |
Why?
|
| Organelles | 1 | 2003 | 20 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2024 | 185 | 0.050 |
Why?
|
| Actomyosin | 1 | 2002 | 7 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2004 | 346 | 0.050 |
Why?
|
| Indoles | 1 | 2024 | 187 | 0.050 |
Why?
|
| Schizosaccharomyces | 1 | 2002 | 17 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2024 | 506 | 0.050 |
Why?
|
| Humans | 4 | 2024 | 43102 | 0.050 |
Why?
|
| Antineoplastic Agents | 2 | 2024 | 1019 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 1869 | 0.040 |
Why?
|
| Sharks | 1 | 2020 | 3 | 0.040 |
Why?
|
| Oogenesis | 1 | 2020 | 29 | 0.040 |
Why?
|
| Imidazoline Receptors | 1 | 2019 | 41 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2024 | 1455 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 200 | 0.030 |
Why?
|
| Rats | 1 | 2024 | 3735 | 0.030 |
Why?
|
| Leukostasis | 1 | 2016 | 4 | 0.030 |
Why?
|
| Blood-Retinal Barrier | 1 | 2016 | 11 | 0.030 |
Why?
|
| Fluorescein Angiography | 1 | 2016 | 8 | 0.030 |
Why?
|
| Fundus Oculi | 1 | 2016 | 7 | 0.030 |
Why?
|
| Retinal Vessels | 1 | 2016 | 29 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2016 | 36 | 0.030 |
Why?
|
| Protease Inhibitors | 1 | 2016 | 54 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2016 | 78 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2016 | 389 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1124 | 0.020 |
Why?
|
| Mitosis | 1 | 2013 | 114 | 0.020 |
Why?
|
| Phylogeny | 1 | 2013 | 769 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2006 | 8 | 0.020 |
Why?
|
| Lysophospholipids | 1 | 2006 | 20 | 0.020 |
Why?
|
| COS Cells | 1 | 2006 | 68 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 64 | 0.020 |
Why?
|
| Male | 2 | 2016 | 23409 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2006 | 168 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2006 | 95 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2004 | 72 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 68 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 294 | 0.010 |
Why?
|
| Biological Transport | 1 | 2004 | 204 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 2157 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 256 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2006 | 986 | 0.010 |
Why?
|
| Female | 1 | 2020 | 24698 | 0.010 |
Why?
|